Patient-preferred Aromatherapy Versus Placebo For Reducing Preoperative Anxiety In Patients Undergoing Eye Surgery
NCT07237061 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2025-11-19
Summary
This study looks at whether aromatherapy (scent chosen by the patient), is better than routine care, at reducing preoperative anxiety before eye surgery.
Conditions
- Cataract
- Surgery
- Vitrectomy
- Aromatherapy
- Preoperative Anxiety
Interventions
- OTHER
-
Aromatherapy
patients chose their preferred aromatherapy scent to be used for at least 30 minutes
- OTHER
-
Placebo
odorless dry absorbent adhesive patch
Sponsors & Collaborators
-
National University Hospital, Singapore
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2024-03-31
- Completion
- 2024-12-01
Countries
- Singapore
Study Locations
More Related Trials
-
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
NCT00703781 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
NCT01367249 ·Status: COMPLETED ·Phase: PHASE3
-
Lidocaine Usage for Pupil Dilatation (Mydriasis)
NCT01170130 ·Status: COMPLETED ·Phase: NA
-
Anesthetic and Dilating Gel for Cataract Surgery
NCT00335400 ·Status: COMPLETED ·Phase: NA
-
Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
NCT02752646 ·Status: COMPLETED ·Phase: NA
-
Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes
NCT00707421 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery
NCT04050644 ·Status: RECRUITING ·Phase: PHASE4
-
Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal
NCT03046719 ·Status: COMPLETED ·Phase: NA
-
Diclofenac vs Dexamethasone in Combined Surgery
NCT00825864 ·Status: COMPLETED ·Phase: NA
-
Patient Assessment of Topical Anesthetic Effectiveness for Intravitreal Injections
NCT01027611 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Protocol of Pupil Dilation Before Laser-assisted Cataract Surgery
NCT03375996 ·Status: COMPLETED
-
Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.
NCT01475643 ·Status: COMPLETED ·Phase: PHASE3
-
Subconjunctival Bupivacaine in Strabismus Surgery
NCT04782960 ·Status: UNKNOWN ·Phase: NA
-
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
NCT00853970 ·Status: COMPLETED ·Phase: PHASE3
-
Hypochlorous Acid Disinfection Prior to Cataract Surgery
NCT04568213 ·Status: COMPLETED ·Phase: PHASE3
-
Povidone-iodine Antisepsis for Strabismus Surgery
NCT00461656 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy
NCT00532415 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Tetracaine 0.5% and Lidocaine 2% Jelly for Topical Phacoemulsification Cataract Surgery
NCT00827073 ·Status: COMPLETED ·Phase: NA
-
Oral Sedation in Vitreoretinal Surgery
NCT04346095 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery
NCT00198445 ·Status: COMPLETED ·Phase: PHASE3
-
Pain Expression in the Perioperative Period of Cataract Surgery
NCT01824927 ·Status: UNKNOWN ·Phase: NA
-
The Influence of PRN Omega-3 Nutritional Supplement on Visual Acuity
NCT02260973 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Topical 0.4% Ketorolac and Vitreoretinal Surgery
NCT00576329 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Use of Prophylactic Lubricating Drops After Cataract Surgery
NCT04131335 ·Status: UNKNOWN ·Phase: NA
-
Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery
NCT00699153 ·Status: COMPLETED ·Phase: PHASE3